Public-registry site landscape for NCT02485652, a Non Small Cell Lung Cancer study sponsored by Hanmi Pharmaceutical Company Limited. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT02485652 (registry record) |
| Sponsor | Hanmi Pharmaceutical Company Limited |
| Condition(s) | Non Small Cell Lung Cancer |
| Phase | PHASE2 |
| Listed sites | 72 |
| Site countries | United States, Australia, Canada, Germany, Italy, Malaysia, Philippines, South Korea, Spain, Taiwan |
Eichor generates a preliminary site-risk snapshot for NCT02485652 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →